Holen Sie sich die Stockscreener-App
18.51
0.64%
0.17
Schlusskurs vom Vortag:
$18.68
Offen:
$19.08
24-Stunden-Volumen:
15,139
Relative Volume:
0.07
Marktkapitalisierung:
$292.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-6.75%
1M Leistung:
-4.76%
6M Leistung:
-11.57%
1J Leistung:
-12.52%
1-Tages-Spanne:
$18.51
$19.13
1-Wochen-Bereich:
$18.13
$20.32
52-Wochen-Spanne:
$6.875
$37.27
Neurogene Inc Stock (NGNE) Company Profile
Firmenname
Neurogene Inc
Sektor
Branche
Telefon
(877) 237-5020
Adresse
535 W 24TH STREET, NEW YORK
Vergleichen Sie NGNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
18.91 | 289.35M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.19 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.84 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.91 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.19 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-17 | Eingeleitet | Craig Hallum | Buy |
| 2025-05-16 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-29 | Eingeleitet | Leerink Partners | Outperform |
| 2024-03-21 | Eingeleitet | William Blair | Outperform |
| 2024-01-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-01-05 | Eingeleitet | Stifel | Buy |
| 2024-01-04 | Eingeleitet | TD Cowen | Outperform |
Alle ansehen
Neurogene Inc Aktie (NGNE) Neueste Nachrichten
Is Neurogene Inc. stock a good choice for value investors2025 Volatility Report & Safe Capital Allocation Plans - ulpravda.ru
Is Neurogene Inc. stock gaining market shareJuly 2025 Macro Moves & Consistent Return Investment Signals - ulpravda.ru
What insider purchases suggest about Neurogene Inc. (UU8) stockJuly 2025 Retail & Safe Entry Point Identification - ulpravda.ru
Neurogene Inc. (NGNE) Stock Analysis: Uncovering a 208% Potential Upside in Biotechnology - DirectorsTalk Interviews
Will Neurogene Inc. (UU8) stock attract long term capital inflows2025 Winners & Losers & Community Verified Trade Alerts - ulpravda.ru
How Neurogene Inc. (UU8) stock correlates with oil marketsAI-Driven Market Analysis & Free Realize Exceptional Returns - ulpravda.ru
Will Neurogene Inc. stock benefit from upcoming earnings reportsStock Price Forecasts & Minimal Investment Big Returns - ulpravda.ru
What analysts say about Neurogene Inc UU8 stockStock Liquidity Analysis & Free Stock Predictions and Analysis - earlytimes.in
Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Bluefield Daily Telegraph
Genetic medicines firm Neurogene opens its health conference talk online - Stock Titan
Neurogene Inc.Common Stock (NQ: NGNE - FinancialContent
Pullback Watch: Is Neurogene Inc stock a good choice for value investorsJuly 2025 Retail & AI Enhanced Trading Signals - moha.gov.vn
Breakout Move: How Applied Industrial Technologies Inc AT4 stock reacts to monetary easingTrend Reversal & Safe Swing Trade Setup Alerts - moha.gov.vn
Here's Why We're Not Too Worried About Neurogene's (NASDAQ:NGNE) Cash Burn Situation - Sahm
Neurogene Inc. (NASDAQ:NGNE) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
What catalysts could drive Neurogene Inc. stock higherPortfolio Diversification Tips & Free Hedging Tactics for Volatile Markets - bollywoodhelpline.com
Sell Signal: Is Neurogene Inc stock gaining market shareJuly 2025 Sentiment & Low Risk High Reward Ideas - moha.gov.vn
Earnings Beat: Is Neurogene Inc stock a good choice for value investorsQuarterly Portfolio Summary & Verified Entry Point Signals - moha.gov.vn
Why Neurogene Inc. stock appeals to dividend seekersQuarterly Profit Summary & Weekly Breakout Watchlists - Улправда
Will Neurogene Inc. stock gain from lower inflationWeekly Trade Report & Daily Price Action Insights - DonanımHaber
Can Neurogene Inc. stock continue upward trend2025 Key Highlights & Expert Verified Movement Alerts - DonanımHaber
Will Neurogene Inc. stock split again soonJuly 2025 Retail & Real-Time Volume Analysis Alerts - Улправда
Will Neurogene Inc. (UU8) stock benefit from Fed rate cutsRecession Risk & AI Powered Market Entry Ideas - DonanımHaber
Momentum Shift: Why Neurogene Inc. stock appeals to dividend seekersWeekly Trade Summary & Weekly High Return Opportunities - Улправда
Can Neurogene Inc. stock maintain operating marginsMarket Risk Report & Precise Trade Entry Recommendations - ulpravda.ru
Can Neurogene Inc. stock deliver surprise earnings beatWeekly Earnings Recap & Risk Managed Trade Strategies - Улправда
Insider Buy: Why Neurogene Inc. stock appeals to dividend seekersQuarterly Portfolio Report & Advanced Technical Analysis Signals - Улправда
Neurogene Earnings Notes - Trefis
Neurogene (NASDAQ:NGNE) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Contrasting Neurogene (NASDAQ:NGNE) & Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Entry Recap: Why Neurogene Inc stock appeals to dividend seekersMarket Trend Summary & Reliable Trade Execution Plans - moha.gov.vn
How Neurogene Inc. stock reacts to job market dataMarket Sentiment Report & Safe Swing Trade Setups - Newser
Will Neurogene Inc. (UU8) stock rise with strong economyEarnings Growth Summary & Weekly Market Pulse Updates - Newser
Will Neurogene Inc. (UU8) stock keep high P E multiplesCPI Data & Low Volatility Stock Recommendations - Newser
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Neurogene (Nasdaq: NGNE) approves inducement stock options for 4,860 shares - Stock Titan
Swing Trade: Can Neurogene Inc stock deliver surprise earnings beatJuly 2025 Retail & Weekly High Momentum Picks - moha.gov.vn
Will Neurogene Inc. (UU8) stock outperform value peers2025 Bull vs Bear & Real-Time Volume Analysis - Newser
Will Neurogene Inc. (UU8) stock profit from automation waveJuly 2025 Catalysts & Weekly High Momentum Picks - Newser
Gene therapy NGN-401 leads to functional gains in Rett syndrome - Rett Syndrome News
Analysts Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $42.50 - Defense World
Is Neurogene Inc. (UU8) stock safe for risk averse investorsJuly 2025 Rallies & Short-Term High Return Strategies - Newser
Is Neurogene Inc. (UU8) stock inflation resilientQuarterly Performance Summary & Risk Managed Trade Strategies - Newser
How institutional buying supports Neurogene Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - Newser
Will Neurogene Inc. (UU8) stock outperform benchmarksJuly 2025 EndofMonth & Community Consensus Stock Picks - Newser
Neurogene (NGNE) Stock Analysis Report | Financials & Insights - Benzinga
Neurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Hold" by Brokerages - MarketBeat
Is Neurogene Inc a good long term investmentPortfolio Diversification Tips & Small Budget Wealth Tips - earlytimes.in
Wall Street analysts’ outlook for Neurogene Inc (NGNE) - Setenews
Companies Like Neurogene (NASDAQ:NGNE) Are In A Position To Invest In Growth - Yahoo Finance
Finanzdaten der Neurogene Inc-Aktie (NGNE)
Es liegen keine Finanzdaten für Neurogene Inc (NGNE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):